Sir,
We read with great interest the paper (Bagos, 2009) . The author conducted a meta-analysis of five case-control studies (223 cases and 393 controls) to estimate the association of C677T polymorphism in methylenetetrahydrofolate reductase (MTHFR) gene with polycystic ovary syndrome (PCOS). His meta-analysis showed no significant difference for association of MTHFR C677T polymorphism with PCOS. It is a valuable study.
Nevertheless, careful examination of the data provided by the author (Table II in the original text) revealed an issue that is worth noticing. The data were from these five studies, only one is in accordance with the original study (Sills et al., 2001) . The data from the other four studies reported by Bagos do not seem in line with the data provided in their original publications (Glueck et al., 1999; Tsanadis et al., 2002; Orio et al., 2003; Palep-Singh et al., 2007) . The number of genotypes CC and TT reported by Bagos for MTHFR C677T polymorphism in cases and controls was reversed. Nevertheless, it seems that the data analysis were performed using the correct genotype frequencies.
We reassessed the association between MTHFR C677T polymorphism and PCOS. This meta-analysis consisted of 288 cases and 453 controls. In addition to the above five studies, two later case -control reports containing the genotype frequency of MTHFR C677T polymorphism were considered (Choi et al., 2009; Karadeniz et al., 2010) . However, two groups (Choi et al., 2009 ) and the Asian subgroup of (Palep-Singh et al., 2007) deviation from Hardy-Weinberg equilibrium in controls were not included. We therefore analyzed six studies on subjects of Caucasian racial descent (Table I) . This meta-analysis also showed that there was no significant difference for association of MTHFR C677T polymorphism with PCOS under the additive model, dominant model and recessive model (Table II) 
